Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruey-Meei Wu

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Acta Medica Okayama|March 5, 2002
Catechol-O-methyltransferase and Parkinson's diseaseChun-Hwi Tai, Ruey-Meei Wu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 18, 2008
Neurocysticercosis presenting with epilepsia partialis continua: a clinicopathologic report and literature reviewShin-Joe Yeh, Ruey-Meei Wu
Journal of Biomedical Science|June 16, 2018
LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a reviewMeng-Ling Chen, Ruey-Meei Wu
Journal of Parkinson'S Disease|May 7, 2014
Application of the University Of Pennsylvania Smell Identification Test (traditional Chinese version) for detecting olfactory deficits in early Parkinson's disease in a Taiwanese cohortChin-Yi Yu, Ruey-Meei Wu
Journal of Biomedical Science|August 14, 2022
Homozygous mutation of the LRRK2 ROC domain as a novel genetic model of parkinsonismMeng-Ling Chen, Ruey-Meei Wu
Nature Reviews. Neurology|June 24, 2020
Parkinson disease risk variants in East Asian populationsRuey-Meei Wu, Matthew J Farrer
Frontiers in Aging Neuroscience|September 23, 2022
Mild cognitive impairment in patients with Parkinson's disease: An updated mini-review and future outlookRwei-Ling Yu, Ruey-Meei Wu
Parkinsonism & Related Disorders|March 5, 2015
Biomarkers of cognitive decline in Parkinson's diseaseChin-Hsien Lin, Ruey-Meei Wu
Translational Neurodegeneration|March 30, 2013
Social brain dysfunctions in patients with Parkinson's disease: a review of theory of mind studiesRwei-Ling Yu, Ruey-Meei Wu
Neurology|January 21, 2018
Does cigarette smoking do nothing but harm?Shinsuke Fujioka, Ruey-Meei Wu, Yoshio Tsuboi
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Acta Medica Okayama|March 5, 2002
Catechol-O-methyltransferase and Parkinson's diseaseChun-Hwi Tai, Ruey-Meei Wu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 18, 2008
Neurocysticercosis presenting with epilepsia partialis continua: a clinicopathologic report and literature reviewShin-Joe Yeh, Ruey-Meei Wu
Journal of Biomedical Science|June 16, 2018
LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a reviewMeng-Ling Chen, Ruey-Meei Wu
Journal of Parkinson'S Disease|May 7, 2014
Application of the University Of Pennsylvania Smell Identification Test (traditional Chinese version) for detecting olfactory deficits in early Parkinson's disease in a Taiwanese cohortChin-Yi Yu, Ruey-Meei Wu
Journal of Biomedical Science|August 14, 2022
Homozygous mutation of the LRRK2 ROC domain as a novel genetic model of parkinsonismMeng-Ling Chen, Ruey-Meei Wu
Nature Reviews. Neurology|June 24, 2020
Parkinson disease risk variants in East Asian populationsRuey-Meei Wu, Matthew J Farrer
Frontiers in Aging Neuroscience|September 23, 2022
Mild cognitive impairment in patients with Parkinson's disease: An updated mini-review and future outlookRwei-Ling Yu, Ruey-Meei Wu
Parkinsonism & Related Disorders|March 5, 2015
Biomarkers of cognitive decline in Parkinson's diseaseChin-Hsien Lin, Ruey-Meei Wu
Translational Neurodegeneration|March 30, 2013
Social brain dysfunctions in patients with Parkinson's disease: a review of theory of mind studiesRwei-Ling Yu, Ruey-Meei Wu
Neurology|January 21, 2018
Does cigarette smoking do nothing but harm?Shinsuke Fujioka, Ruey-Meei Wu, Yoshio Tsuboi
Pageof 16